Clinical Trials Browser

Terminated × INDUSTRY × TH 302 × Clear all

NCT01864538 2025-05-11

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Phase 2 Terminated

11 enrolled 8 charts

Melanoma, Neoplasm Metastasis

NCT02047500 2025-05-11

Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer

Phase 1 Terminated

19 enrolled 6 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02255110 2018-12-14

A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Phase 2 Terminated

6 enrolled 6 charts

Sarcoma